We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-0.26%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$5.52B
AUM Growth
-$337M
Cap. Flow
-$237M
Cap. Flow %
-4.3%
Top 10 Hldgs %
21.83%
Holding
167
New
29
Increased
53
Reduced
66
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 19.07%
2 Financials 19.07%
3 Industrials 15.64%
4 Technology 14.22%
5 Consumer Discretionary 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAC icon
26
Enerpac Tool Group
EPAC
$1.86B
$60.4M 1.1%
2,446,350
-192,375
-7% -$4.43M
CBSH icon
27
Commerce Bancshares
CBSH
$8.75B
$58.9M 1.07%
2,134,561
+16,759
+0.8% +$434K
NTRS icon
28
Northern Trust
NTRS
$22B
$58.3M 1.06%
894,910
+64,660
+8% +$4.05M
QLYS icon
29
Qualys
QLYS
$4.72B
$58.3M 1.06%
2,301,599
-187,320
-8% -$4.86M
RBC icon
30
RBC Bearings
RBC
$17.7B
$56.2M 1.02%
767,440
-127,840
-14% -$8.1M
BRC icon
31
Brady Corp
BRC
$4.55B
$55.3M 1%
2,059,510
+3,835
+0.2% +$92.2K
MDSO
32
DELISTED
Medidata Solutions, Inc.
MDSO
$54.7M 0.99%
1,412,460
+222,435
+19% +$8.65M
AJG icon
33
Arthur J. Gallagher & Co
AJG
$68.8B
$52.1M 0.94%
1,172,030
+11,375
+1% +$454K
PH icon
34
Parker-Hannifin
PH
$121B
$52M 0.94%
468,210
+4,900
+1% +$492K
TRS icon
35
TriMas Corp
TRS
$1.41B
$51.9M 0.94%
2,964,160
-328,145
-10% -$5.61M
NUVA
36
DELISTED
NuVasive, Inc.
NUVA
$51.4M 0.93%
1,057,275
-100,320
-9% -$4.55M
LH icon
37
Labcorp
LH
$25.6B
$51.3M 0.93%
510,001
+26,737
+6% +$2.56M
PTC icon
38
PTC
PTC
$14.9B
$51.3M 0.93%
1,547,500
+18,950
+1% +$585K
XRAY icon
39
Dentsply Sirona
XRAY
$2.79B
$49.9M 0.9%
+810,050
New +$47.7M
ARGO
40
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$49.1M 0.89%
1,082,177
-131,611
-11% -$5.83M
CFR icon
41
Cullen/Frost Bankers
CFR
$10.5B
$48.4M 0.88%
879,045
+41,360
+5% +$2.14M
CMD
42
DELISTED
Cantel Medical Corporation
CMD
$48.3M 0.87%
676,555
-84,650
-11% -$5.31M
CAB
43
DELISTED
Cabela's Inc
CAB
$48.2M 0.87%
990,105
+27,590
+3% +$1.24M
CVBF icon
44
CVB Financial
CVBF
$4.03B
$47.4M 0.86%
2,717,210
-350,100
-11% -$5.52M
MJN
45
DELISTED
Mead Johnson Nutrition Company
MJN
$47M 0.85%
553,405
+6,575
+1% +$489K
COO icon
46
Cooper Companies
COO
$14.2B
$47M 0.85%
1,220,980
+32,200
+3% +$1.11M
SAM icon
47
Boston Beer
SAM
$1.95B
$45.9M 0.83%
248,037
+74,349
+43% +$13.6M
SJM icon
48
J.M. Smucker
SJM
$13.6B
$45.9M 0.83%
353,125
-296,490
-46% -$37.4M
SPLK
49
DELISTED
Splunk Inc
SPLK
$45.3M 0.82%
926,125
+231,845
+33% +$10.4M
WDAY icon
50
Workday
WDAY
$41B
$45.3M 0.82%
589,540
+144,110
+32% +$9.54M

Similar funds

Champlain Investment Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Champlain Investment Partners held 167 positions worth $5.52B, down 5.8% from $5.86B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Champlain Investment Partners withdrew a net $237M in Q1 2016, closing 8 positions and reducing 66 holdings. Its most notable exit was SOLARWINDS INC COM STK (DE), an estimated $77.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

Against the trend, Champlain Investment Partners opened a new position in Dentsply Sirona worth $49.9M.

  • Champlain Investment Partners's largest Q1 2016 buy was Dentsply Sirona: 810,050 shares worth $49.9M.
  • Champlain Investment Partners added most to Snyders-Lance, Inc. in Q1 2016, an estimated $32.5M increase.
  • Champlain Investment Partners's biggest Q1 2016 reduction was J.M. Smucker, cutting an estimated $37.4M.
  • Champlain Investment Partners fully exited SOLARWINDS INC COM STK (DE) in Q1 2016, selling an estimated $77.3M.
  • Champlain Investment Partners's ten largest holdings make up 22% of its $5.52B portfolio in Q1 2016.
  • Champlain Investment Partners opened 29 new positions and closed 8 in Q1 2016.
  • Champlain Investment Partners's portfolio value fell 5.8% quarter-over-quarter to $5.52B.

Based on Champlain Investment Partners's 13F filing for Q1 2016, filed 11 May 2016.